• Assay Selection Tool

BellBrook Labs

  • Products
    • Transcreener® HTS Assays
      • Transcreener® ADP² Kinase Assay
      • Transcreener® ADO CD73 Assay
      • Transcreener® AMP²/GMP² Phosphodiesterase Assay
      • Transcreener® cGAMP cGAS Assay
      • Transcreener® EPIGEN SAH Methyltransferase Assay
      • Transcreener® GDP GTPase Assay Kits
      • Transcreener® UDP² Glycosyltransferase Assay
      • Transcreener® 2-5A OAS Assay
    • AptaFluor® HTS Assays
      • AptaFluor® SAH Methyltransferase Assay
    • HTS Assays by Target Family
      • Kinase Assay Kits
      • ATPase Assay Kits
      • Glycosyltransferase Assay Kits
      • GTPase Assay Kits
        • GAP Assay Kits
        • GEF Assay Kits
      • Ligase and Synthetase Assay Kits
      • Methyltransferase Assay Kits
      • Phosphodiesterase Assay Kits
    • HTS Assays by Target
      • Adenosine Kinase Assay Kits
      • AMPK Assay Kits
      • CD39 Assay Kits
      • CD73 Assay Kits
      • cGAS Assay Kits
      • DDX3 Assay Kits
      • ENPP1 Assay Kits
      • EZH2 Assay Kits
      • IKK-beta Assay Kits
      • IRAK4 Assay Kits
      • JAK1 Assay Kits
      • JAK3 Assay Kits
      • NSP13 Assay Kits
      • NUDT5 Assay Kits
      • OAS Assay Kits
      • PKR Assay Kits
      • TBK1 Assay Kits
    • Recombinant Enzymes
      • Human cGAS Enzyme
      • Mouse cGAS Enzyme
      • Human DDX3 Enzyme
      • Human OAS1 Enzyme
    • Assay Plates
    • Ordering Information
  • Services
    • Assay Development Services
    • Lead Discovery Services
    • CD38 Assay Services
    • GTPase Profiling Services
  • Innate Immunity
    • ADK Activity Assays
    • AMPK Activity Assays
    • cGAS Activity Assays
    • CD73 Activity Assays
    • CD38 Activity Assay Services
    • CD39 Activity Assays
    • DDX3 Activity Assays
    • ENPP1 Activity Assays
    • IKK-beta Activity Assays
    • IRAK4 Activity Assays
    • JAK1 Activity Assays
    • JAK3 Activity Assays
    • NSP13 Activity Assays
    • OAS1 Activity Assays
    • PKR Activity Assays
    • TBK1 Activity Assays
  • Resources
    • Technical Manuals
    • Transcreener® Assays – Instrument Compatibility
    • Application Notes
    • Posters and Presentations
    • Publications
    • Transcreener® FAQ’s
    • Guides
      • Residence Time Guide
      • Hit Prioritization Guide
      • Kinases in Innate Immunity
  • Company
    • President’s Message
    • International Distributors
    • Careers
    • Downloads
    • Contact Us
  • Blog
  • MY CART
    No products in cart.

B4GalT1 – A Druggable Target for the Treatment of Glioblastoma

by Bellbrook Labs / Tuesday, 21 September 2021 / Published in Emerging Targets, HTS Assays
B4GalT1 A Target to Stop Glioblastoma

Multi-faceted Properties of B4GalT1

Beta-1,4-Galactosyltransferase 1 (B4GalT1) belongs to the galactosyltransferase (GalT) family of enzymes that transfer galactose from uridine-diphosphate-α-D-galactose (UDP-Gal) to an acceptor sugar molecule. B4GalT1 is a critical enzyme in galactose metabolism.

One of the first GalT to be characterized biochemically, B4GalT1, was also involved in lactose production by interacting with α-lactalbumin during lactation1. However, more evidence has surfaced over the years illustrating B4GalT1’s role in other physiological processes such as aging2.

 

The Intimate Relationship Between B4GalT1 and Human Cancers

Several new studies have linked B4GalT1 expression to some forms of cancer. B4GalT1 was recently found to be involved in the proliferation and maintenance of cancer stem cells of lung adenocarcinoma3. Another study reported that high B4GalT1 expression in bladder cancer patients was also observed to correlate with low overall survival and expression of inhibitory receptor signals PD-1 and CTLA4. The effectiveness of adjuvant chemotherapy was also found to be higher in bladder cancer patients with lower expression levels of B4GalT14. Elevated B4GalT1 levels were also seen in megakaryocytes from myeloproliferative neoplasms5. Therefore B4GalT1 seems to play an essential role in human cancers, although more work has to be done to thoroughly examine the underlying mechanisms contributing to this relationship.

Targeting B4GalT1 for the Treatment of Glioblastoma

Glioblastoma multiforme (GBM), also known as glioblastoma, is the most aggressive and common form of glioma (a tumor that occurs in the brain and spine)6. Glioblastoma is a fast-growing, grade 4 glioma. Most patients with glioblastoma typically do not survive for more than a year. Due to the tumor’s complexity, glioblastoma remains an incurable disease, and treatment options are still relatively limited.

The involvement of B4GalT1 in glioblastoma is relatively unknown. However, a group of researchers reported for the first time that B4GalT1 expression was elevated in glioblastoma tumor tissue and human primary glioblastoma cells (U87)7. By reducing the expression of B4GalT1 in vitro, the proliferative and migratory capacity of U87 cells was suppressed. Mice injected with U87 cells expressing lower levels of B4GalT1 developed significantly smaller tumors and had a better survival rate than mice injected with normal U87 cells. They also discovered that underlying this phenomenon was that lower B4GalT1 expression induces apoptosis and autophagy of glioblastoma both in vitro and in vivo, therefore promoting cancer cell death. Hence, B4GalT1 plays critical role in regulating glioblastoma development. Targeting B4GalT1 for the treatment of glioblastoma is a highly viable approach that has to be further validated.

BellBrook’s Transcreener UDP2 Assay is a universal UDP detection HTS assay that utilizes a fluorescence-based method to measure glycosyltransferase activity by detecting UDP production.

How the Transcreener UDP2 Assay can facilitate B4GalT1 research:

  • Evaluate enzymatic activity
  • Screen for small molecule inhibitors
  • Determine inhibitor potency/ IC50 values
  • Profile inhibitor selectivity
  • Support mechanistic studies

References

  1. Qasba, P. K., Ramakrishnan, B. & Boeggeman, E. Structure and Function of β-1,4-Galactosyltransferase. Curr Drug Targets 9, 292–309 (2008).
  2. Kremer, J., Brendel, C., Mack, E. K. M. & Mack, H. I. D. Expression of β-1,4-galactosyltransferases during Aging in Caenorhabditis elegans. GER 66, 571–581 (2020).
  3. De Vitis, C. et al. B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells. Journal of Clinical Medicine 8, 1928 (2019).
  4. Xie, H. et al. B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients. BMC Cancer 18, 590 (2018).
  5. Di Buduo, C. A. et al. Increased B4GALT1 expression is associated with platelet surface galactosylation and thrombopoietin plasma levels in MPNs. Blood 137, 2085–2089 (2021).
  6. Holland, E. C. Glioblastoma multiforme: The terminator. Proc Natl Acad Sci U S A 97, 6242–6244 (2000).
  7. Wang, P., Li, X. & Xie, Y. B4GalT1 Regulates Apoptosis and Autophagy of Glioblastoma In Vitro and In Vivo. Technol Cancer Res Treat 19, 1533033820980104 (2020).
Tagged under: B4GalT1 Assay, Glioblastoma Research, Transcreener UDP Assay

What you can read next

Ubiquitin Ligase Assay Tool for Drug Discovery
Ubiquitin Ligase Assay: A Handy Tool for Drug Discovery
Histone Methylation PRMT4
Sensitive Methyltransferase Assay Proves Successful with PRMT4
High Throughput Screening Assays for Drug Discovery
High Throughput Screening Assays for Drug Discovery

Categories

  • Company
  • Emerging Targets
  • Epigenetics
  • HTS Assays
  • Innate Immunity
  • Neurodegenerative Diseases
  • News
  • Products
  • Resources
  • Success Stories
  • Uncategorized

Recent Posts

  • Info book on cancer and RAFK1's relation

    RAF1 & Immunity: A Future Model For Cancer Research?

    RAF1, also known as c-Raf, is a member of the R...
  • OAS1 The Cost of Host Defense

    OAS1: The Cost of Host Defense

    OAS1 (Oligoadenylate synthetase 1) is induced b...
  • Scientist Studying DDX41

    DDX41 as a Sensor, Suppressor, and Modulator

    DDX41 [DEAD (Asp-Glu-Ala-Asp) Box Polypeptide 4...
  • Scientist Studying ALKPK1

    The Role of ALPK1 in Health and Disease

    ALPK1 (Alpha Kinase 1) is an atypical serine/th...
  • DHX36 RNA Helicase Unwinds G4 RNA Structures

    Resolving the Many Roles of DHX36

    While most researchers are familiar with canoni...

Archives

BellBrook Labs
5500 Nobel Drive, Suite 230
Madison, Wisconsin 53711 USA
(608) 443-2400

info@bellbrooklabs.com

 Copyright © 2022 BellBrook Labs | All Rights Reserved | Privacy Policy | Terms of Use | FCOI | Sitemap

TOP